1. Home
  2. BWAY vs DRTS Comparison

BWAY vs DRTS Comparison

Compare BWAY & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • DRTS
  • Stock Information
  • Founded
  • BWAY 2003
  • DRTS 2015
  • Country
  • BWAY Israel
  • DRTS Israel
  • Employees
  • BWAY N/A
  • DRTS N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • DRTS Medical/Dental Instruments
  • Sector
  • BWAY Health Care
  • DRTS Health Care
  • Exchange
  • BWAY Nasdaq
  • DRTS Nasdaq
  • Market Cap
  • BWAY 280.7M
  • DRTS 300.2M
  • IPO Year
  • BWAY 2019
  • DRTS N/A
  • Fundamental
  • Price
  • BWAY $15.77
  • DRTS $3.81
  • Analyst Decision
  • BWAY Strong Buy
  • DRTS Strong Buy
  • Analyst Count
  • BWAY 2
  • DRTS 1
  • Target Price
  • BWAY $18.00
  • DRTS $9.00
  • AVG Volume (30 Days)
  • BWAY 78.9K
  • DRTS 63.6K
  • Earning Date
  • BWAY 11-11-2025
  • DRTS 08-11-2025
  • Dividend Yield
  • BWAY N/A
  • DRTS N/A
  • EPS Growth
  • BWAY 515.14
  • DRTS N/A
  • EPS
  • BWAY 0.11
  • DRTS N/A
  • Revenue
  • BWAY $46,084,000.00
  • DRTS N/A
  • Revenue This Year
  • BWAY $339.49
  • DRTS N/A
  • Revenue Next Year
  • BWAY $21.74
  • DRTS N/A
  • P/E Ratio
  • BWAY $55.73
  • DRTS N/A
  • Revenue Growth
  • BWAY 26.50
  • DRTS N/A
  • 52 Week Low
  • BWAY $7.70
  • DRTS $2.11
  • 52 Week High
  • BWAY $16.25
  • DRTS $4.39
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 67.06
  • DRTS 66.03
  • Support Level
  • BWAY $15.32
  • DRTS $3.51
  • Resistance Level
  • BWAY $16.25
  • DRTS $3.99
  • Average True Range (ATR)
  • BWAY 0.59
  • DRTS 0.18
  • MACD
  • BWAY -0.07
  • DRTS 0.04
  • Stochastic Oscillator
  • BWAY 70.25
  • DRTS 80.00

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Share on Social Networks: